Penicillin-resistant Streptococcus pneumoniae in the Netherlands: results of a 1-year molecular epidemiologic survey

The Journal of Infectious Diseases
P W HermansR de Groot

Abstract

The molecular epidemiologic characteristics of penicillin-resistant pneumococci in the Netherlands were investigated in 1995. Dutch electronic surveillance data showed that 0.7% of all pneumococci were intermediately resistant and 0.4% were highly resistant to penicillin. From March 1995 to March 1996, 89 penicillin-resistant isolates were collected by 39 medical microbiology laboratories. Thirty different genotypes were observed by restriction fragment end labeling. Twenty-one DNA types were unique, whereas 9 distinct genotypes were shared by > or = 2 isolates. Different serogroups were found within 6 of the 9 genetically identical clusters of penicillin-resistant isolates, suggesting that horizontal transfer of capsular genes is common. Finally, nosocomial transmission of penicillin-resistant pneumococci was observed among 21 elderly adults with chronic obstructive pulmonary disease. This study demonstrates that multiple clones of penicillin-resistant pneumococci have been introduced in the Netherlands, a country with a low prevalence of pneumococcal infection. Some clones spread among the population in and outside hospitals.

Citations

Nov 16, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I VickersH Humphreys
May 26, 1999·Diagnostic Microbiology and Infectious Disease·T DaviesP C Appelbaum
Sep 28, 2001·International Journal of Antimicrobial Agents·J Garau
Dec 14, 1999·International Journal of Antimicrobial Agents·H ChardonM Weber
Sep 11, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P M van TilburgP W Hermans
Apr 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Otto G VanderkooiUNKNOWN Toronto Invasive Bacterial Disease Network
Feb 2, 2002·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·K OverwegP W Hermans
May 3, 2001·The Pediatric Infectious Disease Journal·L C OlsonD Bratcher
Sep 17, 2009·Pediatric Emergency Care·Thomas FischerStuart Chale
Jan 25, 2003·Antimicrobial Agents and Chemotherapy·Ralf René ReinertAdnan Al-Lahham
Sep 7, 2006·Journal of Clinical Microbiology·Maren K R SogstadDominique A Caugant
Sep 4, 1998·BMJ : British Medical Journal·H Goossens, M J Sprenger
Jul 11, 1998·Journal of Clinical Pathology·L M Hall
May 19, 2006·Drugs·Francisco Alvarez-LermaMaria-Pilar Gracia-Arnillas
Apr 2, 1998·Pediatric Annals·D A Conrad
Nov 30, 2007·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Thomas FischerHenry C Thode
Mar 5, 2004·Journal of Chemotherapy·S G B Amyes
Jul 17, 2008·Journal of Medical Microbiology·Andrea G Albarracín OrioJosé R Echenique
Nov 10, 2004·International Journal of Medical Microbiology : IJMM·Ralf René Reinert
Oct 18, 2003·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Mohd Nasir-Mohd DesaNavaratnam Parasakthi
Feb 15, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·B E KristiansenL Vorland
Jan 26, 2000·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·M TsoliaT Karpathios
Nov 18, 1998·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·E CastañedaA Tomasz
Oct 1, 1997·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·P W HermansR de Groot
Oct 9, 2003·Journal of Medical Microbiology·Ralf René ReinertRudolf Lütticken
Feb 24, 2001·Acta Paediatrica. Supplement·L SpanjaardL van Alphen
Jul 17, 2003·Pediatric Case Reviews·Paul S Matz
Oct 24, 1998·Infection and Immunity·J R Gilsdorf
Apr 4, 2000·Journal of Clinical Microbiology·E R LawrenceL M Hall
Dec 2, 2000·Journal of Clinical Microbiology·K OverwegP W Hermans
May 15, 1999·Journal of Clinical Microbiology·K OverwegW Hryniewicz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.